Stopping the spread: Targeting tumor metastasis

by Tokyo Medical and Dental UniversityTakahashi et al. show that TGF-β generates a population of cancer cells under cell cycle arrest in G1 phase with high motility by inducing unique Slug/HMGA2-indep

Updated on: January 22,2024 15

Stopping the spread: Targeting tumor metastasis

by Tokyo Medical and Dental UniversityTakahashi et al. show that TGF-β generates a population of cancer cells under cell cycle arrest in G1 phase with high motility by inducing unique Slug/HMGA2-indep

Updated on:January 22,2024 15

Expert highlights the importance of lung cancer screening

by Deb Balzer, Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainScreening for lung cancer can save lives, and there's an urgent need for more screening of people of color. That's one

Updated on: April 07,2024 20

Expert highlights the importance of lung cancer screening

by Deb Balzer, Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainScreening for lung cancer can save lives, and there's an urgent need for more screening of people of color. That's one

Updated on:April 07,2024 20

Experts urge Europe to start planning for lung cancer screening

by University of LiverpoolLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaLeading lung cancer specialists are urging EU countries to take action to initiate life-sa

Updated on: April 07,2024 19

Experts urge Europe to start planning for lung cancer screening

by University of LiverpoolLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaLeading lung cancer specialists are urging EU countries to take action to initiate life-sa

Updated on:April 07,2024 19

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on: October 10,2024 0

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on:October 10,2024 0

Long-term conditions could delay lung cancer diagnosis, new study finds

byUniversity of SussexMedian diagnostic interval by number of AE and CD conditions. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02824-2A new study from researcher

Updated on: September 07,2024 0

Long-term conditions could delay lung cancer diagnosis, new study finds

byUniversity of SussexMedian diagnostic interval by number of AE and CD conditions. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02824-2A new study from researcher

Updated on:September 07,2024 0

Researchers create novel compound targeting melanoma cells

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0An international team of re

Updated on: June 24,2024 3

Researchers create novel compound targeting melanoma cells

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0An international team of re

Updated on:June 24,2024 3

Revealing characteristics of circulating cell-free RNA in the blood of liver cancer patients

byScience China PressMOF materials efficiently enrich circulating nucleic acids (cfDNA and cfRNA) in blood through a simple operational process, enabling various downstream nucleic acid detectio

Updated on: March 30,2024 0

Revealing characteristics of circulating cell-free RNA in the blood of liver cancer patients

byScience China PressMOF materials efficiently enrich circulating nucleic acids (cfDNA and cfRNA) in blood through a simple operational process, enabling various downstream nucleic acid detectio

Updated on:March 30,2024 0

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on: March 30,2024 0

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on:March 30,2024 0

Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

by Shanghai Jiao Tong University Journal CenterCredit:Mechanobiology in Medicine(2023). DOI: 10.1016/j.mbm.2023.100023A new study, led by Prof. Liu from the department of pharmacy, Univers

Updated on: April 30,2024 0

Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

by Shanghai Jiao Tong University Journal CenterCredit:Mechanobiology in Medicine(2023). DOI: 10.1016/j.mbm.2023.100023A new study, led by Prof. Liu from the department of pharmacy, Univers

Updated on:April 30,2024 0

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Updated on: November 30,2024 0

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Updated on:November 30,2024 0

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on: January 02,2024 9

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on:January 02,2024 9

Periostin shows promise to help fight a common form of esophageal cancer

byElsevierSchematic diagram of roles of periostin (POSTN) in the esophageal squamous cell carcinoma (ESCC) microenvironment. Direct contact with ESCC cells leads mesenchymal stem cells (MSCs) to

Updated on: April 28,2024 0

Periostin shows promise to help fight a common form of esophageal cancer

byElsevierSchematic diagram of roles of periostin (POSTN) in the esophageal squamous cell carcinoma (ESCC) microenvironment. Direct contact with ESCC cells leads mesenchymal stem cells (MSCs) to

Updated on:April 28,2024 0